In conclusion, our results demonstrate that SH2 profiling can recognize distinct patterns of EGFR signaling in lung cancer cells, and more broadly provides a straightforward and comprehensive approach to profile the global state of tyrosine phosphorylation signaling in tumors. This evidence concerns the gene EGFR and lung cancer.